Edgewise Therapeutics, Inc.

EWTX

Our mission is to discover new medicines that improve the lives of people facing serious muscle disease. Our science-driven culture places patients first as we start with their unmet needs and then work towards developing therapies to help address the significant challenges of serious muscle diseases.

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$4.08B

EPS-$1.85

P/E-20.29

P/FCF-25.66

EV/EBITDA-18.31

FCF Yield–

Div. Yield–

Net Debt/FCF0.4x

Edgewise Therapeutics, Inc. intrinsic value

52-Week Range

$17.09$48.35

Profitability & Returns

TTM as of 2026-06 · YoY vs prior year · ROIC = NOPAT / invested capital

Revenue

N/A

Net Income (TTM)

-$197M

▼ -25.4% YoY

Op. Margin

–

ROIC

-33.94%

▲ +1.3pp YoY

Cash Flow & Balance Sheet

FCF = operating cash flow + capex · Net debt = total debt − cash · Balance sheet from latest filing

FCF (TTM)

-$159M

▼ -30.6% YoY

Op. Cash Flow (TTM)

-$158M

▼ -31.9% YoY

Net Debt

-$69M

Net Cash Position

Cash & Equiv.

$72M

Continue Research

Quality Scorecard

Is this a high-quality business?

Dividends

Payout safety and growth

Intrinsic Value

What is it worth?

Financials

Full income, cash flow, balance sheet

Peers

Pharmaceutical Preparations · Pick stocks to compare with EWTX

CompareIntrinsic value

ORGOOrganogenesis Holdings Inc.

$0.87+4.19%50

AUPHAurinia Pharmaceuticals Inc.

$17.11+3.32%58

PRAXPraxis Precision Medicines Inc.

$284.79+1.53%10

VNDAVanda Pharmaceuticals Inc.

$3.88+3.47%10

CYRXCryoport Inc.

$16.70+1.52%13

BRNSBarinthus Biotherapeutics plc.

No recent price10

ARDXArdelyx Inc.

$3.27+7.92%40

LLYEli Lilly and Company

$1,418.07+0.62%73

Held by ETFs

EWTX is in 44 US ETFs. The largest of them, with EWTX's weight in each:

Edgewise Therapeutics (EWTX) in two numbers

Dividend: None; No dividend in the SEC filings we hold.; Dividends
P/E: -20.29; Negative: a loss over the last twelve months. Price to free cash flow -25.66.; Financials

Questions about Edgewise Therapeutics

Does Edgewise Therapeutics (EWTX) pay a dividend?

No. Edgewise Therapeutics (EWTX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 31 Jul 2026 (period ending 30 Jun 2026), SEC. Price: last close 4 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in EWTX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing EWTX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.